Theravance Biopharma, Inc. Shares Issued
Theravance Biopharma, Inc. (TBPH) had Shares Issued of 51.89 million shares as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Equity › Stockholders' Equity, Number of Shares, Par Value and Other Disclosure › Common Stock, Number of Shares, Par Value and Other Disclosure
us-gaap:CommonStockSharesIssued · last filed 2026-08-11
- 2026-06-30: Common Stock, Shares, Issued 51.89M shares.
- 2026-03-31: Common Stock, Shares, Issued 51.52M shares.
- 2025-12-31: Common Stock, Shares, Issued 51.07M shares.
- 2025-09-30: Common Stock, Shares, Issued 50.67M shares.
| Period end | Common Stock, Shares, Issued |
|---|---|
| 2026-06-30 | 51.89M shares 10-Q · filed 2026-08-11 |
| 2026-03-31 | 51.52M shares 10-Q · filed 2026-05-07 |
| 2025-12-31 | 51.07M shares 10-Q · filed 2026-08-11 |
| 2025-09-30 | 50.67M shares 10-Q · filed 2025-11-12 |
| 2025-06-30 | 50.36M shares 10-Q · filed 2025-08-13 |
| 2025-03-31 | 50.00M shares 10-Q · filed 2025-05-12 |
| 2024-12-31 | 49.47M shares 10-K · filed 2026-03-23 |
| 2024-09-30 | 49.17M shares 10-Q · filed 2024-11-14 |
| 2024-06-30 | 48.92M shares 10-Q · filed 2024-08-08 |
| 2024-03-31 | 48.57M shares 10-Q · filed 2024-05-15 |
| 2023-12-31 | 48.09M shares 10-K · filed 2025-03-07 |
| 2023-09-30 | 50.82M shares 10-Q · filed 2023-11-09 |
| 2023-06-30 | 53.69M shares 10-Q · filed 2023-08-09 |
| 2023-03-31 | 60.54M shares 10-Q · filed 2023-05-10 |
| 2022-12-31 | 65.23M shares 10-K · filed 2024-03-01 |
| 2022-09-30 | 67.37M shares 10-Q · filed 2022-11-09 |
| 2022-06-30 | 76.43M shares 10-Q · filed 2022-08-08 |
| 2022-03-31 | 76.08M shares 10-Q · filed 2022-05-06 |
| 2021-12-31 | 74.44M shares 10-K · filed 2023-03-01 |
| 2021-09-30 | 73.70M shares 10-Q · filed 2021-11-08 |
| 2021-06-30 | 73.47M shares 10-Q · filed 2021-08-05 |
| 2021-03-31 | 65.22M shares 10-Q · filed 2021-05-06 |
| 2020-12-31 | 64.33M shares 10-K · filed 2022-02-28 |
| 2020-09-30 | 63.96M shares 10-Q · filed 2020-11-09 |
| 2020-06-30 | 63.52M shares 10-Q · filed 2020-08-10 |
| 2020-03-31 | 63.00M shares 10-Q · filed 2020-05-08 |
| 2019-12-31 | 57.02M shares 10-K · filed 2021-02-26 |
| 2019-09-30 | 56.76M shares 10-Q · filed 2019-11-08 |
| 2019-06-30 | 56.64M shares 10-Q · filed 2019-08-05 |
| 2019-03-31 | 56.12M shares 10-Q · filed 2019-05-10 |
| 2018-12-31 | 55.68M shares 10-K · filed 2020-02-27 |
| 2018-09-30 | 55.41M shares 10-Q · filed 2018-11-08 |
| 2018-06-30 | 55.10M shares 10-Q · filed 2018-08-02 |
| 2018-03-31 | 54.80M shares 10-Q · filed 2018-05-09 |
| 2017-12-31 | 54.38M shares 10-K · filed 2019-02-28 |
| 2017-09-30 | 54.09M shares 10-Q · filed 2017-11-08 |
| 2017-06-30 | 53.83M shares 10-Q · filed 2017-08-09 |
| 2017-03-31 | 53.29M shares 10-Q · filed 2017-05-10 |
| 2016-12-31 | 52.83M shares 10-K · filed 2018-02-28 |
| 2016-09-30 | 48.09M shares 10-Q · filed 2016-11-09 |
| 2016-06-30 | 47.85M shares 10-Q · filed 2016-08-09 |
| 2016-03-31 | 41.45M shares 10-Q · filed 2016-05-10 |
| 2015-12-31 | 37.98M shares 10-K · filed 2017-03-01 |
| 2015-09-30 | 33.94M shares 10-Q · filed 2015-11-12 |
| 2015-06-30 | 33.94M shares 10-Q · filed 2015-08-13 |
| 2015-03-31 | 33.80M shares 10-Q · filed 2015-05-13 |
| 2014-12-31 | 32.22M shares 10-K · filed 2016-03-11 |
| 2014-09-30 | 32.23M shares 10-Q · filed 2014-11-12 |
| 2014-06-30 | 32.26M shares 10-Q · filed 2014-08-14 |
| 2013-12-31 | 0.00 shares 10-K · filed 2015-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cryoport, Inc. (CYRX) | United States | $0.881B | -21.29 |
| RIGEL PHARMACEUTICALS INC (RIGL) | United States | $0.893B | 2.25 |
| Apnimed, Inc. (APMD) | United States | $0.899B | |
| ARDELYX, INC. (ARDX) | United States | $0.857B | -22.86 |
| Avalo Therapeutics, Inc. (AVTX) | United States | $0.842B | -9.74 |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |
| Jade Biosciences, Inc. (JBIO) | United States | $0.936B | -9.21 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |